Abstract
Beta-lactams are a group of drugs considered to be the treatment of choice in cases of salmonellosis, although many isolates that are clinically resistant to these compounds have been reported. We developed an in vitro model to determine the dynamics of the generation of resistant mutants following repeated exposure to these drugs. All the isolates exposed repeatedly to amoxicillin and cefotaxime exhibit a decrease in their susceptibility to these compounds and to many other beta-lactam drugs. However, in many cases this reduction in susceptibility is not detected if the CLSI criteria are applied. These mutants with reduced susceptibility may be the reason for therapeutic failures, so this phenomenon should be studied in greater detail by means of in vitro models or clinical studies.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
EJ Threlfall IS Fisher C Berghold P Gerner-Smidt H Tschape M Cormican et al. (2003) ArticleTitleAntimicrobial drug resistance in isolates of Salmonella enterica from cases of salmonellosis in humans in Europe in 2000: results of international multi-centre surveillance Eur Surveill 8 41–5 Occurrence Handle1:STN:280:DC%2BD3s7nt1Sjuw%3D%3D
E Giraud A Cloeckaert D Kerboeuf E Chaslus-Dancla (2000) ArticleTitleEvidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar typhimurium Antimicrob Agents Chemother 44 1223–8 Occurrence Handle10.1128/AAC.44.5.1223-1228.2000 Occurrence Handle1:CAS:528:DC%2BD3cXislKisb0%3D Occurrence Handle10770755
E Giraud A Brisabois JL Martel E Chaslus-Dancla (1999) ArticleTitleComparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field Antimicrob Agents Chemother 43 2131–7 Occurrence Handle1:CAS:528:DyaK1MXlvVGrtL8%3D Occurrence Handle10471553
AA Delsol MJ Woodward JM Roe (2004) ArticleTitleEffect of a 5 day enrofloxacin treatment on Salmonella enterica serotype Typhimurium DT104 in the pig J Antimicrob Chemother 53 396–8 Occurrence Handle10.1093/jac/dkh038 Occurrence Handle1:CAS:528:DC%2BD2cXos1aqsA%3D%3D Occurrence Handle14711838
L Cebrian E Sirvent JC Rodríguez DÍaz M Ruiz G Royo (2003) ArticleTitleCharacterisation of Salmonella spp. mutants produced by exposure to various fluoroquinolones Int J Antimicrob Agents 22 134–9 Occurrence Handle10.1016/S0924-8579(03)00099-2 Occurrence Handle1:CAS:528:DC%2BD3sXmsVKitbo%3D Occurrence Handle12927953
A Gupta J Fontana C Crowe B Bolstorff A Stout S Van Duyne et al. (2003) ArticleTitleEmergence of multidrug-resistant Salmonella enterica serotype Newport infections resistant to expanded-spectrum cephalosporins in the United States J Infect Dis 188 1707–16 Occurrence Handle10.1086/379668 Occurrence Handle1:CAS:528:DC%2BD2cXktlOhtw%3D%3D Occurrence Handle14639542
LH Su CH Chiu C Chu MH Wang JH Chia TL Wu (2003) ArticleTitleIn vivo acquisition of ceftriaxone resistance in Salmonella enterica serotype anatum Antimicrob Agents Chemother 47 IssueID2 563–7 Occurrence Handle10.1128/AAC.47.2.563-567.2003 Occurrence Handle1:CAS:528:DC%2BD3sXhtVWmt7w%3D Occurrence Handle12543660
SA Carlson KE Ferris (2000) ArticleTitleAugmentation of antibiotic resistance in Salmonella typhimurium DT104 following exposure to penicillin derivatives Vet Microbiol 73 25–35 Occurrence Handle10.1016/S0378-1135(00)00154-1 Occurrence Handle1:CAS:528:DC%2BD3cXhvVOkt7g%3D Occurrence Handle10731615
F Moulin H Sauve-Martin E Marc MM Lorrot M Soulier S Ravilly et al. (2003) ArticleTitleCiprofloxacin after clinical failure of beta-lactam antibiotics in children with salmonellosis Arch Pediatr 10 608–14 Occurrence Handle10.1016/S0929-693X(03)00281-1 Occurrence Handle1:STN:280:DC%2BD3sznt1SmsA%3D%3D Occurrence Handle12907068
MA Gordon HT Banda M Gondwe SB Gordon MJ Boeree AL Walsh et al. (2002) ArticleTitleNon-typhoidal Salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence AIDS 16 IssueID12 1633–41 Occurrence Handle10.1097/00002030-200208160-00009 Occurrence Handle12172085
I Chopra AJ O'Neill K Miller (2003) ArticleTitleThe role of mutators in the emergence of antibiotic-resistant bacteria Drug Resist Update 6 137–45 Occurrence Handle10.1016/S1368-7646(03)00041-4 Occurrence Handle1:CAS:528:DC%2BD3sXlsVSmtL4%3D
MI Morosini JA Ayala F Baquero JL Martinez J Blazquez (2000) ArticleTitleBiological cost of AmpC production for Salmonella enterica serotype Typhimurium Antimicrob Agents Chemother 44 3137–43 Occurrence Handle10.1128/AAC.44.11.3137-3143.2000 Occurrence Handle1:CAS:528:DC%2BD3cXnvVSis7g%3D Occurrence Handle11036037
MK Glynn V Reddy L Hutwagner T Rabatsky-Ehr B Shiferaw DJ Vugia et al. (2004) ArticleTitlePrior antimicrobial agent use increases the risk of sporadic infections with multidrug-resistant Salmonella enterica serotype Typhimurium: a FoodNet case-control study, 1996–1997 Clin Infect Dis 38 IssueIDsuppl 3 S227–36 Occurrence Handle10.1086/381591 Occurrence Handle15095194
JA Crump TJ Barrett JT Nelson FJ Angulo (2003) ArticleTitleReevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae Clin Infect Dis 37 75–81 Occurrence Handle10.1086/375602 Occurrence Handle12830411
FM Aarestrup C Wiuff K Molbak EJ Threlfall (2003) ArticleTitleIs it time to change fluoroquinolone breakpoints for Salmonella spp.? Antimicrob Agents Chemother 47 827–9 Occurrence Handle10.1128/AAC.47.2.827-829.2003 Occurrence Handle1:CAS:528:DC%2BD3sXhtVWmu7g%3D Occurrence Handle12543704
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Cebrián, L., Rodríguez, J., Escribano, I. et al. In vitro generation of Salmonella spp. mutants following repeated exposure to β-lactam antibiotics. J Infect Chemother 12, 80–82 (2006). https://doi.org/10.1007/s10156-005-0430-y
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10156-005-0430-y